Literature DB >> 8169409

Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction.

T Weber1, R W Turner, S Frye, B Ruf, J Haas, E Schielke, H D Pohle, W Lüke, W Lüer, K Felgenhauer.   

Abstract

Using polymerase chain reaction (PCR), 34 cerebrospinal fluid (CSF) samples from 28 patients with progressive multifocal leukoencephalopathy (PML) were analyzed. As controls, 116 samples were evaluated from 82 human immunodeficiency virus type 1 (HIV-1)-infected patients and 1 HIV-1-negative patient. Of the HIV-1-positive patients, 23 had cerebral toxoplasmosis, 10 had HIV leukoencephalopathy, and 49 had other neurologic complications. Detection of JC virus (JCV) DNA in CSF was increased 10-fold by the addition of carrier DNA before phenol-chloroform-isoamyl alcohol extraction. The primer pair JC 26/29, from the VP1/large T region, had a limit of detection of 10(5) JCV DNA molecules/100 microL. The primer pair JC 36/39, located in the large T gene region, had a 100-fold lower limit of detection. With JC 26/29, the sensitivity was 43% (12/28) and specificity was 100%. Using JC 36/39, sensitivity increased to 82% (23/28), and false-positive results were not observed. Diagnosis of PML is greatly aided by PCR analysis of CSF.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8169409     DOI: 10.1093/infdis/169.5.1138

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: formation of virus-like particles useful for immunological and therapeutic studies.

Authors:  C Goldmann; H Petry; S Frye; O Ast; S Ebitsch; K D Jentsch; F J Kaup; F Weber; C Trebst; T Nisslein; G Hunsmann; T Weber; W Lüke
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Increased frequency of JC virus type 2 and of dual infection with JC virus type 1 and 2 in Italian progressive multifocal leukoencephalopathy patients.

Authors:  P Ferrante; M Mediati; R Caldarelli-Stefano; L Losciale; R Mancuso; A E Cagni; R Maserati
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

3.  Cortical blindness in a 35-year-old man.

Authors:  C Rickards; D I Shepherd
Journal:  Postgrad Med J       Date:  1996-04       Impact factor: 2.401

4.  Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy.

Authors:  Angela Marzocchetti; Simona Di Giambenedetto; Antonella Cingolani; Adriana Ammassari; Roberto Cauda; Andrea De Luca
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  Functional comparison of PML-type and archetype strains of JC virus.

Authors:  E Sock; K Renner; D Feist; H Leger; M Wegner
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team.

Authors:  M J Post; C Yiannoutsos; D Simpson; J Booss; D B Clifford; B Cohen; J C McArthur; C D Hall
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

7.  Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy.

Authors:  I W Fong; C B Britton; K E Luinstra; E Toma; J B Mahony
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

8.  Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals.

Authors:  H T Agostini; C F Ryschkewitsch; G L Stoner
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

Review 9.  [Progressive multifocal leukoencephalopathy].

Authors:  J C Wasmuth; A Wasmuth-Pietzuch; U Spengler; J K Rockstroh
Journal:  Med Klin (Munich)       Date:  1999-05-15

Review 10.  Central nervous system infections in individuals with HIV-1 infection.

Authors:  Arunima Mamidi; Joseph A DeSimone; Roger J Pomerantz
Journal:  J Neurovirol       Date:  2002-06       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.